PMID: Summary Keywords Crohns disease, GLP, GLP-1, GLP-2 receptor agonist, IBD - inflammatory bowel disease, ulcerative colitis Citation Lee JJ, Bajgain P and Lightner AL (2026) GLP-1 and GLP-2 as intestinal reparative therapies in inflammatory bowel disease: mechanisms, translation, and clinical opportunity
Protein intake and resistance training become especially important during GLP-1 treatment
However, according to legal complaints, some Zepbound patients claim this injectable tirzepatide caused them to suffer from stomach paralysis, functional bowel obstructions (ileus), pancreatitis, blood clots, and other conditions
Yet changing dietary habits is crucial on these powerful drugs, especially since data shows that about half of people quit within a year, then rapidly regain weight
So from this perspective, its really an absolute bargain
Glutathione S-transferases liberate hydrogen cyanide from organic thiocyanates